ACADIAN ASSET MANAGEMENT LLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 84 filers reported holding RELMADA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 2.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,577
-34.8%
1,193,333
+1.0%
0.01%
-42.1%
Q1 2024$5,490
+12.2%
1,181,186
-0.1%
0.02%0.0%
Q4 2023$4,893
+39.3%
1,182,825
+0.9%
0.02%
+26.7%
Q3 2023$3,513
+17.1%
1,172,723
-4.0%
0.02%
+25.0%
Q2 2023$2,999
+8.9%
1,221,3990.0%0.01%0.0%
Q1 2023$2,755
-28.1%
1,221,399
+11.0%
0.01%
-36.8%
Q4 2022$3,8341,100,3390.02%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Deep Track Capital, LP 2,837,818$9,903,9850.42%
Sio Capital Management, LLC 235,500$821,8950.30%
Sio Capital Management, LLC 235,600$822,2440.30%
apricus wealth, LLC 77,329$269,8780.25%
RTW INVESTMENTS, LP 2,067,824$7,216,7060.15%
PARSONS CAPITAL MANAGEMENT INC/RI 496,254$1,731,9260.14%
Aristides Capital LLC 69,322$241,9340.12%
XTX Topco Ltd 129,387$451,5610.10%
AdvisorShares Investments LLC 81,362$283,9530.08%
Ikarian Capital, LLC 65,491$228,5630.06%
View complete list of RELMADA THERAPEUTICS INC shareholders